Core Viewpoint - Ctrip (09961) shows signs of a potential short-term rebound despite a recent decline, with technical indicators suggesting a strong buy signal due to oversold conditions [1][2]. Group 1: Stock Performance - On January 29, Ctrip's stock closed at 482.2 HKD, down 2.66% with a trading volume of 20.16 billion HKD, indicating a lack of significant bottom-fishing activity [1]. - Ctrip's performance was similar to that of NetEase (09999), both experiencing declines over 2.5%, while Baidu (09888) only saw a minor drop of 0.38% [1]. - The Relative Strength Index (RSI) for Ctrip is at 38, indicating it is in the oversold territory, suggesting a potential for a technical rebound [1]. Group 2: Technical Indicators - Multiple moving averages have issued strong buy signals for Ctrip, with a signal strength of 9, indicating a robust buy recommendation [1]. - The short-term moving average pressure is evident, with a need for the stock to surpass the MA10 at 483.58 HKD for a rebound to be confirmed [1]. Group 3: Support and Resistance Levels - As of January 30, Ctrip's latest price is 485 HKD, reflecting a 0.58% increase, with resistance levels identified at 531 HKD (Resistance 1) and 585 HKD (Resistance 2) [2]. - Short-term support levels are at 457 HKD (Support 1) and 379 HKD (Support 2), with a 56% probability of a rebound if the stock can maintain above the 457 HKD support [2]. Group 4: Derivative Products - Two call options are highlighted for investors expecting a short-term rebound: - Morley Call Option (24926) with a leverage of 4.7 and an exercise price of 531.38 HKD, noted for its low premium [6]. - Morgan Call Option (24761) with a leverage of 4.6 and a slightly lower exercise price of 530.88 HKD, suitable for conservative investors [6]. - Two put options are recommended for those anticipating continued downward movement: - Bank of China Put Option (19962) with a leverage of 11.4 and an exercise price of 420.88 HKD, ideal for high-risk tolerance investors [7]. - Morley Put Option (20768) with a leverage of 12.4 and a balanced risk profile, suitable for investors seeking to capitalize on price declines [8].